Compare ACHV & AGCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHV | AGCC |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.5M | 660.6M |
| IPO Year | 2018 | 2025 |
| Metric | ACHV | AGCC |
|---|---|---|
| Price | $7.00 | $15.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $14.15 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 15.4K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $168.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $4.23 |
| 52 Week High | $8.64 | $25.73 |
| Indicator | ACHV | AGCC |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 55.06 |
| Support Level | $6.92 | $14.17 |
| Resistance Level | $7.11 | $15.75 |
| Average True Range (ATR) | 0.38 | 0.67 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 13.10 | 69.75 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.